Azithromycin Tablet, Film Coated
NDC Package 62332-252-30
Package Information
Azithromycin tablets is azithromycin is used to treat a wide variety of bacterial infections. This formulation utilizes a tablet, film coated delivery system. Marketed by Alembic Pharmaceuticals Inc., this product is identified by NDC 62332-252 and is authorized under FDA application ANDA211792.
Identification & Billing
- RxCUI: 248656 - azithromycin 500 MG Oral Tablet
- RxCUI: 248656 - azithromycin 500 MG (as azithromycin monohydrate) Oral Tablet
- RxCUI: 749780 - {3 (azithromycin 500 MG Oral Tablet) } Pack
- RxCUI: 749780 - azithromycin 500 MG Oral Tablet 3 Count Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62332 - Alembic Pharmaceuticals Inc.
- 62332-252 - Azithromycin
- 62332-252-30 - 30 TABLET, FILM COATED in 1 BOTTLE
- 62332-252 - Azithromycin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62332-252). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62332-252-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Azithromycin, a human prescription drug labeled by Alembic Pharmaceuticals Inc.. This tablet, film coated is formulated for oral use and contains azithromycin dihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Inc. on January 29, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Azithromycin is used to treat a wide variety of bacterial infections. It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Alembic Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62332025230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.